Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Orally active androgens

Orally active androgens

US Patent 6541465 · Granted Apr 1, 2003

Estimated economic value: $897,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ring-annulated dihydropyrrolo[2,1-α]isoquinolines2013
(Dihydro)pyrrolo[2,1-α]isoquinolines2013
Substituted 16,17-annellated steroid compounds for use in womens healthcare2013
Non-steroidal androgens compounds2012
(Dihydro)imidazoiso[5,1-A]quinolines2011
Dihydrobenzoindazoles2011
16,17-carbocyclic condensed steroid compounds having selective estrogenic activi2011
15 β-substituted steroids having selective estrogenic activity2010
Androgens2010
Indoles useful in the treatment of androgen-receptor related diseases2010
16Alpha-methyl or ethyl substituted estrogens2010
Steroids having a mixed androgenic and progestagenic profile2009